Jacob Chacko - 15 Dec 2022 Form 4/A - Amendment Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
President and CEO, Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
15 Dec 2022
Net transactions value
-$18,859
Form type
4/A - Amendment
Filing time
17 Feb 2023, 15:22:44 UTC
Date Of Original Report
16 Dec 2022
Previous filing
21 Jul 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale $18,859 -6,137 -0.75% $3.07 816,652 15 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.